Thursday, March 28, 2024
name of Prensa Latina
Bandera inglesa
English Edition
Search
Close this search box.
name of Prensa Latina

NEWS

clinical trial

Havana, Jan 31 (Prensa Latina) A phase III clinical trial to evaluate the efficacy and safety of the nasal administration of NeuroEPO in adult patients with spinocerebellar ataxias is being successfully developed in Cuba.
Havana, Jul 14 (Prensa Latina) Cuba is nowadays showing remarkable progress in the clinical trial of the drug NeuralCIM (NeuroEPO) to fight off Alzheimer's disease, a saddening ailment that really affects thousands of people around the globe.
New Delhi, Aug 15 (Prensa Latina) Bharat Biotech International Limited (BBIL) on Monday announced that its intra-nasal vaccine (BBV154) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.
Havana, Dec 7 (Prensa Latina) One year has passed since the beginning of phase I and II of clinical trial with the then vaccine candidate Abdala, the results of which allowed its validation for emergency use to become the first immunizer against Covid-19 in Latin America.